Thioredoxin signaling as a target for cancer therapy
Top Cited Papers
- 3 July 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 7 (4), 392-397
- https://doi.org/10.1016/j.coph.2007.04.003
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid TumorsClinical Cancer Research, 2007
- Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress‐mediated diseasesThe Journal of Dermatology, 2006
- Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-α Expression but Decrease Functional Transcriptional Activity, DNA Binding, and DegradationClinical Cancer Research, 2006
- The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structureBiochemical Journal, 2006
- Hcc‐2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinomaFEBS Letters, 2006
- Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxinAnti-Cancer Drugs, 2006
- High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast CancerClinical Cancer Research, 2005
- Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic CancerCancer Research, 2004
- Decreased enzyme activity of hepatic thioredoxin reductase and glutathione reductase in rabbits by prolonged exposure to inorganic arsenateEnvironmental Toxicology and Water Quality, 2003
- ERdj5, an Endoplasmic Reticulum (ER)-resident Protein Containing DnaJ and Thioredoxin Domains, Is Expressed in Secretory Cells or following ER StressJournal of Biological Chemistry, 2003